Syncona Partners

VC London, United Kingdom ·Founded 2012

Overview

Syncona Partners was founded in 2012 and operates as an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential to significantly impact the healthcare market of the future. Syncona is an investor that can take the long view when necessary, able to concentrate investment into opportunities as technology is validated. Syncona Partners is an independent subsidiary of the Wellcome Trust who invested the initial £200m capitalization. Syncona Partners provides financial resources to individuals and companies to advance the Wellcome Trust's vision of achieving extraordinary improvements in human and animal health by supporting the brightest minds in biomedical research and the medical humanities. The fund invests in life sciences companies

Investment Focus

  • Focus on life sciences and healthcare sectors
  • Companies with innovative technologies and strong growth potential
  • Commitment to sustainable and responsible business practices

Portfolio Companies

Achilles TherapeuticsBeacon TherapeuticsBicycle TherapeuticsiOncturaAutolus TherapeuticsAnaveonNightstaRxMereo BioPharmaSlingshot TherapeuticsOMass TherapeuticsSpur TherapeuticsYellowstone BiosciencesForcefield TherapeuticsResolution TherapeuticsPurespring TherapeuticsMosaic Therapeutics

Reach Syncona Partners directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Syncona Partners

What sectors does Syncona Partners invest in?

Syncona Partners invests in Healthcare, Life Sciences, Pharmaceuticals and Biotechnology, and is based in London, United Kingdom. Syncona Partners is listed as a vc in the ConnectSafely investor database.

What stage does Syncona Partners invest at?

Syncona Partners backs companies at Series A, Series B and Growth, writing cheques of 2M - 100M.

Which regions does Syncona Partners invest in?

Syncona Partners invests across United States, United Kingdom, Germany and Switzerland.

What companies has Syncona Partners invested in?

Syncona Partners's portfolio includes Achilles Therapeutics, Beacon Therapeutics, Bicycle Therapeutics, iOnctura, Autolus Therapeutics, Anaveon, NightstaRx and Mereo BioPharma.

How do I contact Syncona Partners?

Syncona Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.

Last updated · Source: ConnectSafely investor database